• 2007

Company Description

Fabrus identifies and develops functional therapeutic monoclonal antibodies to challenging cell surface targets like GPCRs and ion channels.

Fabrus LLC was founded in 2007 as the first company in The Pfizer Incubator. The company has assembled a seasoned scientific team that has met and exceeded its milestones by establishing a unique antibody discovery platform and discovering multiple preclinical lead candidates against important cancer targets.